In fact, increase of IL-27 in cerebrospinal fluid of patients with multiple sclerosis correlates with suppression of neuroinflammation (14), underscoring therapeutic potential of IL-27 as treatment for human CNS autoimmune diseases. Here, IL27 is linked to multiple sclerosis.